Immunic Statistics

Total Valuation

Immunic has a market cap or net worth of $118.00 million. The enterprise value is $39.26 million.

Market Cap	118.00M
Enterprise Value	39.26M

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024, before market open.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

Immunic has 90.08 million shares outstanding. The number of shares has increased by 82.57% in one year.

Shares Outstanding	90.08M
Shares Change (YoY)	+82.57%
Shares Change (QoQ)	+4.08%
Owned by Insiders (%)	1.16%
Owned by Institutions (%)	25.29%
Float	52.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.86
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.75, with a Debt / Equity ratio of 0.02.

Current Ratio	3.75
Quick Ratio	3.58
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -143.47% and return on invested capital (ROIC) is -86.26%.

Return on Equity (ROE)	-143.47%
Return on Assets (ROA)	-66.80%
Return on Capital (ROIC)	-86.26%
Revenue Per Employee	n/a
Profits Per Employee	-$1.24M
Employee Count	77
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +23.59% in the last 52 weeks. The beta is 1.84, so Immunic's price volatility has been higher than the market average.

Beta (5Y)	1.84
52-Week Price Change	+23.59%
50-Day Moving Average	1.52
200-Day Moving Average	1.34
Relative Strength Index (RSI)	37.01
Average Volume (20 Days)	1,046,642

Short Selling Information

The latest short interest is 3.47 million, so 3.85% of the outstanding shares have been sold short.

Short Interest	3.47M
Short Previous Month	2.68M
Short % of Shares Out	3.85%
Short % of Float	6.65%
Short Ratio (days to cover)	5.76

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-93.65M
Pretax Income	-95.31M
Net Income	-95.31M
EBITDA	-93.53M
EBIT	-93.65M
Earnings Per Share (EPS)	-$1.32

Full Income Statement

Balance Sheet

The company has $79.70 million in cash and $955,000 in debt, giving a net cash position of $78.74 million or $0.87 per share.

Cash & Cash Equivalents	79.70M
Total Debt	955,000
Net Cash	78.74M
Net Cash Per Share	$0.87
Equity (Book Value)	63.57M
Book Value Per Share	0.71
Working Capital	62.30M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$72.34 million and capital expenditures -$420,000, giving a free cash flow of -$72.76 million.

Operating Cash Flow	-72.34M
Capital Expenditures	-420,000
Free Cash Flow	-72.76M
FCF Per Share	-$0.81

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Immunic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-82.57%
Shareholder Yield	-82.57%
Earnings Yield	-80.76%
FCF Yield	-61.66%

Analyst Forecast

The average price target for Immunic is $13.20, which is 907.63% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.20
Price Target Difference	907.63%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1